➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
Johnson and Johnson
Express Scripts
McKinsey
Mallinckrodt

Last Updated: September 21, 2020

DrugPatentWatch Database Preview

ETHACRYNATE SODIUM Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

US ANDA Litigation and Generic Entry Outlook for Ethacrynate Sodium

A generic version of ETHACRYNATE SODIUM was approved as ethacrynate sodium by PAR STERILE PRODUCTS on July 29th, 2015.

  Start Trial

Summary for ETHACRYNATE SODIUM
Drug patent expirations by year for ETHACRYNATE SODIUM
Pharmacology for ETHACRYNATE SODIUM

US Patents and Regulatory Information for ETHACRYNATE SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Institutional ETHACRYNATE SODIUM ethacrynate sodium INJECTABLE;INJECTION 204634-001 Aug 23, 2016 AP RX No No   Start Trial   Start Trial   Start Trial
Zydus Pharms ETHACRYNATE SODIUM ethacrynate sodium INJECTABLE;INJECTION 207758-001 Nov 17, 2017 AP RX No No   Start Trial   Start Trial   Start Trial
Par Sterile Products ETHACRYNATE SODIUM ethacrynate sodium INJECTABLE;INJECTION 205473-001 Jul 29, 2015 AP RX No No   Start Trial   Start Trial   Start Trial
Vpi Pharms Inc ETHACRYNATE SODIUM ethacrynate sodium INJECTABLE;INJECTION 208663-001 Jun 9, 2020 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Johnson and Johnson
AstraZeneca
McKesson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.